These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 27032379)
1. Expression of MMP and TIMP mRNA in peripheral blood leukocytes of patients with invasive ductal carcinoma of the breast. Wieczorek E; Galicki M; Tomasik B; Krol M; Jablonska E; Fendler W; Gromadzinska J; Morawiec Z; Wasowicz W; Reszka E Int J Biol Markers; 2016 Jul; 31(3):e309-16. PubMed ID: 27032379 [TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study. Pietruszewska W; Bojanowska-Poźniak K; Kobos J Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931 [TBL] [Abstract][Full Text] [Related]
3. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma. Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214 [TBL] [Abstract][Full Text] [Related]
4. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer. Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083 [TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer. Gong YL; Xu GM; Huang WD; Chen LB J Surg Oncol; 2000 Feb; 73(2):95-9. PubMed ID: 10694645 [TBL] [Abstract][Full Text] [Related]
6. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma. Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530 [TBL] [Abstract][Full Text] [Related]
7. Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast. Kim HJ; Park CI; Park BW; Lee HD; Jung WH Yonsei Med J; 2006 Jun; 47(3):333-42. PubMed ID: 16807982 [TBL] [Abstract][Full Text] [Related]
8. Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder. Staack A; Badendieck S; Schnorr D; Loening SA; Jung K BMC Urol; 2006 Aug; 6():19. PubMed ID: 16901349 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase expression patterns in luminal A type breast carcinomas. Decock J; Hendrickx W; Drijkoningen M; Wildiers H; Neven P; Smeets A; Paridaens R Dis Markers; 2007; 23(3):189-96. PubMed ID: 17473389 [TBL] [Abstract][Full Text] [Related]
10. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. Soini Y; Satta J; Määttä M; Autio-Harmainen H J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Feldman LJ; Mazighi M; Scheuble A; Deux JF; De Benedetti E; Badier-Commander C; Brambilla E; Henin D; Steg PG; Jacob MP Circulation; 2001 Jun; 103(25):3117-22. PubMed ID: 11425778 [TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of collagenolysis associated with stress urinary incontinence in women with urethral hypermobility vs intrinsic sphincter deficiency. Candoso B; Meneses MJ; Alves MG; Sousa M; Oliveira PF Neurourol Urodyn; 2019 Aug; 38(6):1533-1539. PubMed ID: 31099099 [TBL] [Abstract][Full Text] [Related]
14. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. Bramhall SR; Neoptolemos JP; Stamp GW; Lemoine NR J Pathol; 1997 Jul; 182(3):347-55. PubMed ID: 9349239 [TBL] [Abstract][Full Text] [Related]
15. Is determination of matrix metalloproteinases and their tissue inhibitors serum concentrations useful in patients with gastroenteropancreatic and bronchopulmonary neuroendocrine neoplasms? Blicharz-Dorniak J; Kos-Kudła B; Foltyn W; Kajdaniuk D; Marek B; Zemczak A; Strzelczyk J Endokrynol Pol; 2012; 63(6):470-6. PubMed ID: 23339005 [TBL] [Abstract][Full Text] [Related]
16. The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue. Piechota-Polanczyk A; Demyanets S; Mittlboeck M; Hofmann M; Domenig CM; Neumayer C; Wojta J; Klinger M; Nanobachvili J; Huk I Eur J Vasc Endovasc Surg; 2015 May; 49(5):549-55. PubMed ID: 25800096 [TBL] [Abstract][Full Text] [Related]
17. Variability of MMP/TIMP and TGF-β1 Receptors throughout the Clinical Progression of Chronic Venous Disease. Serralheiro P; Novais A; Cairrão E; Maia C; Costa Almeida CM; Verde I Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267209 [TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. Simi L; Andreani M; Davini F; Janni A; Pazzagli M; Serio M; Orlando C Lung Cancer; 2004 Aug; 45(2):171-9. PubMed ID: 15246188 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility. Wieczorek E; Reszka E; Jablonowski Z; Jablonska E; Krol MB; Grzegorczyk A; Gromadzinska J; Sosnowski M; Wasowicz W BJU Int; 2013 Dec; 112(8):1207-14. PubMed ID: 23819551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]